Monoclonal Anti-Influenza A virus (Victoria/4897/2022) NP Antibody, Mouse IgG1 (3B3) (MALS verified)

Source

Monoclonal Anti-Influenza A virus (Victoria/4897/2022) NP Antibody, Mouse IgG1 (3B3) is a recombinant mouse monoclonal antibody expressed in HEK293 cells.

Antibody Type

Recombinant Monoclonal

Clone

3B3

Isotype

Mouse IgG1, Kappa

Host Species

Mouse

Reactivity

Virus

Immunogen

Recombinant Influenza A virus (Victoria/4897/2022) NP (H1N1) Protein is expressed from human 293 cells

Specificity

Specifically recognizes Influenza A virus (Victoria/4897/2022) NP (H1N1) Protein in ELISA with: Influenza A virus (Wisconsin/67/2022) NP (H1N1) Protein.

Application

Purification

Protein A purified / Protein G purified.

Aggregation

Less than 5%, as determined by SEC-MALS.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

1. -20°C to -70°C for 12 months in lyophilized state;
2. -70°C for 3 months under sterile conditions after reconstitution.

Notices

Product Specific Notices: For research use only.

ACRO Quality Management System

1. QMS(ISO, GMP)
2. Quality Advantages
3. Quality Control Process